AstraZeneca advances toward broad-spectrum cancer vaccine development

AstraZeneca announced plans to develop cancer vaccines targeting a broad patient population rather than niche cases. This signals a strategic expansion into therapeutic vaccines, though no clinical data or timeline was provided. The move could reshape oncology treatment if successful, but remains early-stage.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works